[go: up one dir, main page]

GB0319358D0 - Treatment of neurodegenerative conditions - Google Patents

Treatment of neurodegenerative conditions

Info

Publication number
GB0319358D0
GB0319358D0 GB0319358A GB0319358A GB0319358D0 GB 0319358 D0 GB0319358 D0 GB 0319358D0 GB 0319358 A GB0319358 A GB 0319358A GB 0319358 A GB0319358 A GB 0319358A GB 0319358 D0 GB0319358 D0 GB 0319358D0
Authority
GB
United Kingdom
Prior art keywords
treatment
neurodegenerative conditions
neurodegenerative
conditions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0319358A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BTG International Ltd
Original Assignee
BTG International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BTG International Ltd filed Critical BTG International Ltd
Priority to GB0319358A priority Critical patent/GB0319358D0/en
Publication of GB0319358D0 publication Critical patent/GB0319358D0/en
Priority to JP2006523678A priority patent/JP2007502805A/en
Priority to ES200650014A priority patent/ES2304094B2/en
Priority to CN200480030644XA priority patent/CN1867328B/en
Priority to DE112004001520T priority patent/DE112004001520B4/en
Priority to CH00249/06A priority patent/CH698539A8/en
Priority to US10/567,778 priority patent/US7964641B2/en
Priority to AU2004266480A priority patent/AU2004266480B2/en
Priority to GB0724618A priority patent/GB2442161B/en
Priority to EP11157375A priority patent/EP2324828A1/en
Priority to FI20060154A priority patent/FI20060154A7/en
Priority to PCT/GB2004/003524 priority patent/WO2005018632A1/en
Priority to EP04768085A priority patent/EP1660071A1/en
Priority to GB0725392A priority patent/GB2442164B/en
Priority to CA2534202A priority patent/CA2534202C/en
Priority to GB0603646A priority patent/GB2422373B/en
Priority to IS8246A priority patent/IS8246A/en
Priority to NO20061232A priority patent/NO20061232L/en
Priority to US12/654,780 priority patent/US20100113810A1/en
Priority to US12/654,779 priority patent/US20100113595A1/en
Priority to US13/363,705 priority patent/US20120142775A1/en
Ceased legal-status Critical Current

Links

GB0319358A 2003-08-18 2003-08-18 Treatment of neurodegenerative conditions Ceased GB0319358D0 (en)

Priority Applications (21)

Application Number Priority Date Filing Date Title
GB0319358A GB0319358D0 (en) 2003-08-18 2003-08-18 Treatment of neurodegenerative conditions
GB0603646A GB2422373B (en) 2003-08-18 2004-08-13 Treatment of neurodegenerative conditions
FI20060154A FI20060154A7 (en) 2003-08-18 2004-08-13 Treatment of neurodegenerative conditions
EP04768085A EP1660071A1 (en) 2003-08-18 2004-08-13 Treatment of neurodegenerative conditions
CN200480030644XA CN1867328B (en) 2003-08-18 2004-08-13 Use of lipid glycerides for the manufacture of medicaments for the treatment of neurodegenerative conditions
DE112004001520T DE112004001520B4 (en) 2003-08-18 2004-08-13 Use of a lipid glyceride of specified structure for the manufacture of a medicament for the treatment of multiple sclerosis
CH00249/06A CH698539A8 (en) 2003-08-18 2004-08-13 Compounds with unsaturated fatty acid residues for the preparation of medicaments for the treatment of multiple sclerosis.
US10/567,778 US7964641B2 (en) 2003-08-18 2004-08-13 Treatment of neurodegenerative conditions
AU2004266480A AU2004266480B2 (en) 2003-08-18 2004-08-13 Treatment of neurodegenerative conditions
GB0724618A GB2442161B (en) 2003-08-18 2004-08-13 Triglycerides
EP11157375A EP2324828A1 (en) 2003-08-18 2004-08-13 Treatment for neurodegenerative conditions
JP2006523678A JP2007502805A (en) 2003-08-18 2004-08-13 Treatment of neurodegenerative conditions
PCT/GB2004/003524 WO2005018632A1 (en) 2003-08-18 2004-08-13 Treatment of neurodegenerative conditions
ES200650014A ES2304094B2 (en) 2003-08-18 2004-08-13 TREATMENT OF NEURODEGENERATIVE DOLENCES.
GB0725392A GB2442164B (en) 2003-08-18 2004-08-13 Treatment of neurodegenerative conditions
CA2534202A CA2534202C (en) 2003-08-18 2004-08-13 Lipid glycerides for the treatment of neurodegenerative conditions involving demyelination
IS8246A IS8246A (en) 2003-08-18 2006-01-19 Treatment of neurodegenerative conditions
NO20061232A NO20061232L (en) 2003-08-18 2006-03-17 Treatment of neurodegenerative conditions
US12/654,780 US20100113810A1 (en) 2003-08-18 2009-12-31 Treatment of neurodegenerative conditions
US12/654,779 US20100113595A1 (en) 2003-08-18 2009-12-31 Treatment of neurodegenerative conditions
US13/363,705 US20120142775A1 (en) 2003-08-18 2012-02-01 Treatment of neurodegenerative conditions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0319358A GB0319358D0 (en) 2003-08-18 2003-08-18 Treatment of neurodegenerative conditions

Publications (1)

Publication Number Publication Date
GB0319358D0 true GB0319358D0 (en) 2003-09-17

Family

ID=28052689

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0319358A Ceased GB0319358D0 (en) 2003-08-18 2003-08-18 Treatment of neurodegenerative conditions

Country Status (2)

Country Link
CN (1) CN1867328B (en)
GB (1) GB0319358D0 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4701469A (en) * 1983-04-15 1987-10-20 Roussel Uclaf Triglycerides, process for therapeutical applications and compositions containing them
JP2003535892A (en) * 2000-06-23 2003-12-02 イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム 2-Arachidonylglycerol (2-AG)-an inhibitor of tumor necrosis factor-alpha and neuroprotective factor of the brain in closed head injury
JP2003048831A (en) * 2001-08-02 2003-02-21 Suntory Ltd Composition having preventing and ameliorating action on symptom or disease caused by decrease in brain function

Also Published As

Publication number Publication date
CN1867328A (en) 2006-11-22
CN1867328B (en) 2010-12-29

Similar Documents

Publication Publication Date Title
GB2415378B (en) Treatment of neurodegenerative conditions
GB2422373B (en) Treatment of neurodegenerative conditions
EG24420A (en) Treatment of ophthalmic conditions
EP1689485A4 (en) Cardioelectromagnetic treatment
EP1617844A4 (en) Treatment of neurological conditions
EP1654260A4 (en) 6-menbered heteroaryl compounds for the treatment of neurodegenerative disorders
GB0326486D0 (en) Combination treatment
EP1658072A4 (en) Compounds for the treatment of neurodegenerative disorders
IL175535A0 (en) Compositions for treatment of neurodegenerative diseases
GB0312407D0 (en) Treatment
EP1653982A4 (en) Treatment of malodour
GB0300783D0 (en) Treatment of neurodegenerative conditions
GB0302572D0 (en) Method of treatment
AU2003259833A8 (en) Methods of treating neurodegenerative diseases
GB0306309D0 (en) Method of treatment
EP1691776A4 (en) Treatment of aids
GB0329416D0 (en) Treatment of cancer
GB2422600B (en) Sludge treatment
GB2442164B (en) Treatment of neurodegenerative conditions
GB0724618D0 (en) Treatment of neurodegenerative conditions
GB0319358D0 (en) Treatment of neurodegenerative conditions
GB0327975D0 (en) Methods of treatment
GB0325838D0 (en) Wastewater treatment
HK1091138A (en) Treatment of neurodegenerative conditions
GB0410846D0 (en) Treatment of neurodegenerative conditions

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)